Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Piperacillin")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1017

  • Page / 41
Export

Selection :

  • and

Risk factors for piperacillin/tazobactam-resistant Escherichia coli in ICU patients: a clinical studyMOHAMMEDI, Ismaël; PLOIN, Dominique; DUPERRET, Serge et al.Intensive care medicine (Print). 2003, Vol 29, Num 7, pp 1164-1168, issn 0342-4642, 5 p.Article

Serological studies of piperacillin antibodiesLEGER, Regina M; ARNDT, Patricia A; GARRATTY, George et al.Transfusion (Philadelphia, PA). 2008, Vol 48, Num 11, pp 2429-2434, issn 0041-1132, 6 p.Article

Piperacillin-induced immune hemolysis: new cases and a concise review of the literatureMAYER, Beate; YÜREK, Salih; SALAMA, Abdulgabar et al.Transfusion (Philadelphia, PA). 2010, Vol 50, Num 5, pp 1135-1138, issn 0041-1132, 4 p.Article

Noncovalent Complexes of an Inactive Mutant of CTX-M-9 with the Substrate Piperacillin and the Corresponding ProductLEYSSENE, David; DELMAS, Julien; ROBIN, Frederic et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 12, pp 5660-5665, issn 0066-4804, 6 p.Article

Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interactionWALSH, Thomas J; SHOHAM, Shmuel; PETRAITIENE, Ruta et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 10, pp 4744-4748, issn 0095-1137, 5 p.Article

Intervention study of the association of antibiotic utilization measures with control of extended-spectrum β-lactamase (ESBL)-producing bacteriaZHONGGUANG WEN; XIAOYANG WEI; YONGHONG XIAO et al.Microbes and infection. 2010, Vol 12, Num 10, pp 710-715, issn 1286-4579, 6 p.Article

Concentrations of piperacillin-tazobactam in human jaw and hip boneAL-NAWAS, Bilal; KINZIG-SCHIPPERS, Marion; SOERGEL, Fritz et al.Journal of cranio-maxillo-facial surgery. 2008, Vol 36, Num 8, pp 468-472, issn 1010-5182, 5 p.Article

False positive galactomannan Platelia due to piperacillin-tazobactamGERLINGER, M. P; ROUSSELOT, P; RIGAUDEAU, S et al.Médecine et maladies infectieuses. 2012, Vol 42, Num 1, pp 10-14, issn 0399-077X, 5 p.Article

Relationship between pharmacokinetics and pharmacodynamics of β-lactams and outcomeSDDABA, B; AZANZA, J. R; CAMPANERO, M. A et al.Clinical microbiology and infection. 2004, Vol 10, Num 11, pp 990-998, issn 1198-743X, 9 p.Article

In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn®, Wyeth) formulationJONES, Ronald N; FRITSCHE, Thomas R; MOET, Gary J et al.Diagnostic microbiology and infectious disease. 2008, Vol 61, Num 1, pp 76-79, issn 0732-8893, 4 p.Article

False-positive Aspergillus antigen testing due to application of piperacillin/tazobactam : is it still an issue?PENACK, Olaf; REMPF, Patricia; GRAF, Barbara et al.Diagnostic microbiology and infectious disease. 2008, Vol 60, Num 1, pp 117-120, issn 0732-8893, 4 p.Article

Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotypeSADER, Helio S; HSIUNG, Andre; FRITSCHE, Thomas R et al.Diagnostic microbiology and infectious disease. 2007, Vol 57, Num 3, pp 341-344, issn 0732-8893, 4 p.Article

Pseudomonas aeruginosa β-lactamase as a defence against azlocillin, mezlocillin and piperacillinJACOBS, J. Y; LIVERMORE, D. M; DAVY, K. W. M et al.Journal of antimicrobial chemotherapy (Print). 1984, Vol 14, Num 3, pp 221-229, issn 0305-7453Article

Population Pharmacokinetics of Piperacillin Using Scavenged Samples From Preterm InfantsCOHEN-WOLKOWIEZ, Michael; BENJAMIN, Daniel K; OUELLET, Daniele et al.Therapeutic drug monitoring. 2012, Vol 34, Num 3, pp 312-319, issn 0163-4356, 8 p.Article

A novel way to investigate the effects of plasma exchange on antibiotic levels : use of microdialysisROBERTS, Jason A; ROBERTS, Michael S; ROBERTSON, Thomas A et al.International journal of antimicrobial agents. 2008, Vol 31, Num 3, pp 240-244, issn 0924-8579, 5 p.Article

Optimized LC-MS/MS quantification method for the detection of piperacillin and application to the development of charged liposaccharides as oral penetration enhancersVIOLETTE, Aude; FARIA CORTES, Diego A; BERGEON, Julie A et al.International journal of pharmaceutics. 2008, Vol 351, Num 1-2, pp 152-157, issn 0378-5173, 6 p.Article

Post-antibiotic effect induced by an antibiotic combination : influence of altered susceptibility to individual componentsLI, Ronald C; TANG, Mei C.Journal of antimicrobial chemotherapy (Print). 2005, Vol 55, Num 4, pp 583-586, issn 0305-7453, 4 p.Article

γ-Irradiation effects on the thermal decomposition behaviour and IR absorption spectra of piperacillinMAHFOUZ, R. M; GAFFAR, M. A; ABU EL-FADL, A et al.Radiation effects and defects in solids. 2003, Vol 158, Num 11-12, pp 827-832, issn 1042-0150, 6 p.Article

Population Pharmacokinetic Analysis of Piperacillin in Burn PatientsSANGIL JEON; SEUNGHOON HAN; JONGTAE LEE et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 7, pp 3744-3751, issn 0066-4804, 8 p.Article

Pharmacokinetics of Intravenous Piperacillin Administration in Patients Undergoing On-Line HemodiafiltrationOH, Kook-Hwan; KIM, Chiweon; LEE, Hankyu et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 8, pp 3266-3268, issn 0066-4804, 3 p.Article

Antibiotics and immunomodulation: effects of cefotaxime, amikacin, nezlocillin, piperacillin and clindamycinROSZKOWSKI, W; KO, H. L; ROSZKOWSKI, K et al.Medical microbiology and immunology. 1985, Vol 173, Num 5, pp 279-289, issn 0300-8584Article

Inhibition of flucloxacillin tubular renal secretion by piperacillinLANDERSDORFER, Cornelia B; KIRKPATRICK, Carl M. J; KINZIG, Martina et al.British journal of clinical pharmacology. 2008, Vol 66, Num 5, pp 648-659, issn 0306-5251, 12 p.Article

Reproducibility assessment of tigecycline MIC results by broth microdilution methods using commercially prepared dry-form panelsRHOMBERG, Paul R; JONES, Ronald N.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 1, pp 67-69, issn 0732-8893, 3 p.Article

Individualization of Piperacillin Dosing for Critically III Patients: Dosing Software To Optimize Antimicrobial TherapyFELTON, T. W; ROBERTS, J. A; LODISE, T. P et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 7, pp 4094-4102, issn 0066-4804, 9 p.Article

Synthesis and antibacterial activity of a modified nuclear analogue of piperacillinDRIVER, M. J; BENTLEY, P. H; DIXON, R. A et al.Journal of antibiotics (Tokyo. 1968). 1984, Vol 37, Num 3, pp 297-299, issn 0021-8820Article

  • Page / 41